# FDA Inspection 1181313 - Sazerac North America, Inc. - September 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/sazerac-north-america-inc/5af65e0c-2ade-453a-9cc9-ea248c89202f
Source feed: FDA_Inspections

> FDA Inspection 1181313 for Sazerac North America, Inc. on September 19, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181313
- Company Name: Sazerac North America, Inc.
- Inspection Date: 2022-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 980254 - 2016-08-03](https://www.keypedia.com/records/fda_inspections/sazerac-north-america-inc/eaf7ab0f-5a6b-4382-bfab-e82bdd2851d1)

Company: https://www.keypedia.com/companies/sazerac-north-america-inc/6f9d24ea-e2bf-4957-9878-1264814b381d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c